MedTrace Logo

OPEP Devices in Acute Inpatient Treatment of Pneumonia

NCT04540510 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 11

Last updated 2021-09-24

Study results available
· View outcomes & findings →

Summary

This is a randomized-controlled prospective study to be conducted at Danbury Hospital and Norwalk Hospital to evaluate oscillatory positive expiratory pressure (OPEP) devices for "airway clearance" (helping to clear out phlegm or mucous from your lungs and bronchial tubes) in the treatment of patients admitted to the hospital with pneumonia.

Approximately 200 subjects are expected to participate in this study.

Conditions

  • Community-acquired Pneumonia

Interventions

DEVICE

OPEP therapy

Oscillatory Positive Expiratory Pressure therapy

OTHER

Standard care

Standard pneumonia care

Sponsors & Collaborators

  • Danbury Hospital

    lead OTHER

Principal Investigators

  • Amy Ahasic, MD · Nuvance Health

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-08-13
Primary Completion
2021-02-18
Completion
2021-02-18
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04540510 on ClinicalTrials.gov